Gait disorders can be caused by a variety of conditions, including neurological, muscular, and structural abnormalities. One common gait disorder is hemiplegic gait, which is characterized by unilateral weakness on the affected side, with the arm flexed, adducted, and internally rotated, and the leg on the same side in extension with plantar flexion of the foot and toes. When walking, the patient may hold their arm to one side and drag their affected leg in a semicircle (circumduction) due to weakness of leg flexors and extended foot. Hemiplegic gait is often seen in patients who have suffered a stroke.

Other gait disorders include ataxic gait, spastic gait, and steppage gait, each with their own unique characteristics and associated conditions. Accurate diagnosis and treatment of gait disorders is important for improving mobility and quality of life for affected individuals.

Late onset psychosis has a higher prevalence in females and is often associated with sensory impairment, particularly hearing loss. Auditory hallucinations are the most common type of hallucination experienced in late onset psychosis, while visual, somatic, and olfactory hallucinations are less common. Compared to individuals without psychosis, those with late onset psychosis tend to have larger cerebral ventricles and more cognitive impairment. There is no reported association with social class. Patients with late onset psychosis are more likely to be unmarried and have lower fecundity. While there is an increased risk of schizophrenia in first-degree relatives, this risk is approximately half of that found in first-degree relatives of young individuals with schizophrenia.

REM sleep is facilitated by the presence of acetylcholine (Ach), while dopamine, histamine, noradrenaline, and serotonin act as inhibitors of sleep.

Starting to sit unsupported at 8 months is considered normal as it falls within the expected range of achieving this milestone by 9 months. However, the other choices suggest a delay in development.

The Emergence of Social Smiling in Infants

Wormann (2014) discusses the emergence of social smiling in infants, which is usually interpreted as the first positive expression directed towards a cause. This occurs when an infant with an initially expressionless face examines the face of another person, and their face and eyes light up while the corners of their mouth pull upward. The age of the first appearance of the social smile varies across cultures, ranging from the fifth to seventh week. Additionally, there are differences in its duration and frequency between the second and seventh month of life. Understanding these milestones is important for a basic understanding of normal child development.

Child Development Milestones:
4 weeks Responds to noise (either by crying, of quieting), follows an object moved in front of eyes
6 weeks Begins social smiling*
3 months Holds head steady on sitting
6 months Rolls from stomach to back, starts babbling
7 months Transfers objects from hand to hand, looks for dropped object
9 months Sits unsupported, begins to crawl
12 months Cruising (walking by holding furniture)
18 months Walks without assistance, speaks about 10-20 words
2 years Runs, climbs up and down stairs alone, makes 2-3 word sentences
3 years Dresses self except for buttons and laces, counts to 10, feeds themself well
4 years Hops on one foot, copies a cross
5 years Copies a triangle, skips

This is an instance of a primary delusion known as delusional perception.

Borderline Learning Disability

Borderline learning disability is a term used to describe individuals with an IQ between 70-85. This category is not officially recognized as a diagnosis by the ICD-11. It is estimated that approximately 15% of the population falls within this range (Chaplin, 2005). Unlike mild learning disability, borderline learning disability is not typically associated with deficits in adaptive functioning, such as grooming, dressing, safety, of money management.

If serum clozapine levels remain elevated, it is recommended to add anticonvulsant cover due to the increased risk of seizures and EEG changes. While some clinicians may advocate for higher clozapine levels, there is limited evidence to support this practice. Amisulpride can be used to augment clozapine, but it is not necessary in this situation. Beta-blockers are used to treat persistent tachycardia caused by clozapine, while hyoscine hydrobromide is used to manage clozapine-associated hypersalivation. Loperamide is unlikely to be needed as clozapine is known to cause constipation.

Solanezumab is a type of humanised monoclonal antibody that can bind to the central region of β-amyloid, which is believed to prevent the formation of plaques. However, current research has not yet determined whether this drug is effective in treating Alzheimer’s dementia.

Carbimazole is a medication that is commonly used to treat hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone.

Levomilnacipran is a newly approved drug by the FDA that is used to treat major depressive disorder.

Pantoprazole is a type of proton pump inhibitor that is used to treat acid reflux disease, a condition in which stomach acid flows back into the esophagus.

Zubsolv is a recently approved drug by the FDA that is used for the maintenance treatment of opioid dependence.

Lithium – Pharmacology

Pharmacokinetics:
Lithium salts are rapidly absorbed following oral administration and are almost exclusively excreted by the kidneys unchanged. Blood samples for lithium should be taken 12 hours post-dose.

Ebstein’s:
Ebstein’s anomaly is a congenital malformation consisting of a prolapse of the tricuspid valve into the right ventricle. It occurs in 1:20,000 of the general population. Initial data suggested it was more common in those using lithium but this had not held to be true.

Contraindications:
Addison’s disease, Brugada syndrome, cardiac disease associated with rhythm disorders, clinically significant renal impairment, untreated of untreatable hypothyroidism, low sodium levels.

Side-effects:
Common side effects include nausea, tremor, polyuria/polydipsia, rash/dermatitis, blurred vision, dizziness, decreased appetite, drowsiness, metallic taste, and diarrhea. Side-effects are often dose-related.

Long-term use is associated with hypothyroidism, hyperthyroidism, hypercalcemia/hyperparathyroidism, irreversible nephrogenic diabetes insipidus, and reduced GFR.

Lithium-induced diabetes insipidus:
Treatment options include stopping lithium (if feasible), keeping levels within 0.4-0.8 mmol/L, once-daily dose of the drug taken at bedtime, amiloride, thiazide diuretics, indomethacin, and desmopressin.

Toxicity:
Lithium salts have a narrow therapeutic/toxic ratio. Risk factors for lithium toxicity include drugs altering renal function, decreased circulating volume, infections, fever, decreased oral intake of water, renal insufficiency, and nephrogenic diabetes insipidus. Features of lithium toxicity include GI symptoms and neuro symptoms.

Pre-prescribing:
Before prescribing lithium, renal function, cardiac function, thyroid function, FBC, and BMI should be checked. Women of childbearing age should be advised regarding contraception, and information about toxicity should be provided.

Monitoring:
Lithium blood levels should be checked weekly until stable, and then every 3-6 months once stable. Thyroid and renal function should be checked every 6 months. Patients should be issued with an information booklet, alert card, and record book.

Courtesy stigma refers to the stigma that friends and family members of a person with a mental illness may experience due to their association with the affected individual. This can lead to secrecy about the diagnosis. Enacted stigma is the actual experience of discrimination, while felt stigma is the fear of discrimination that can prevent people from seeking help. Public stigma is the negative attitudes and reactions of the general population towards those with mental illness. Self-stigma is the internalized prejudice and reduced sense of self-worth that individuals with mental illness may experience. These terms were first introduced by Goffman in 1963.

An Overview of Anxiety Disorders

Anxiety disorders are a group of mental health conditions that are characterised by excessive and persistent feelings of fear, worry, and apprehension. There are several types of anxiety disorders, each with its own unique set of symptoms and diagnostic criteria.

Social phobia, also known as social anxiety disorder, is characterised by intermittent anxiety that is associated with specific social situations. Individuals with social phobia often feel the need to perform of fear being scrutinised in these situations, leading to avoidance as a maladaptive coping strategy.

Generalised anxiety disorder, on the other hand, is characterised by persistent free-floating anxiety that is not necessarily tied to any specific situation of trigger.

Paranoid personality disorder is not typically associated with anxiety as a key feature, although individuals with this condition may experience other symptoms such as suspiciousness and mistrust.

In contrast, paranoid schizophrenia may involve self-referential delusions, although the cognitive distortions seen in social phobia are not considered delusional.

Finally, specific phobia is a category of anxiety disorders that involves intense fear of anxiety in response to a specific object of situation, such as heights of spiders.